← All research updates

Hyperbaric oxygen added to drug treatment for newly found glioblastoma

Original title: Adebrelimab Plus Temozolomide ± Hyperbaric Oxygen for Primary Glioblastoma

How far along is this research?

This is a trial that is enrolling or has been updated. It is not a finding yet.

This is a middle stage trial, so the idea is still being tested.

Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.

The trial team last updated this record on . Always check the trial page for the latest.

The short version

This study tests if hyperbaric oxygen helps drug treatment work better for glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary.

Who this trial is for. This trial is for people with a newly found glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary. They must have had surgery or a biopsy first. They must also have finished chemo and radiation given together. Some people get the drugs adebrelimab and temozolomide along with hyperbaric oxygen. Others get the drugs without it.

Where it stands. This trial has not reported results. It is measuring how long people go without the tumor growing. It also looks at how long people live, how tumors respond, how people are doing day to day, and side effects. The answers are not in yet.

What this means, and what it doesn't

What it could mean: Someone who fits this picture could ask their care team about this trial. The care team can say if it makes sense for them. Hyperbaric oxygen is being tested here as an add on. Nobody knows yet if it helps.

What it doesn't mean: This does not mean the treatment works. A trial is a test, not proven care. Being in one does not promise any benefit. It is not a promise of a cure.

Source: ClinicalTrials.gov, August 27, 2026 · Read the original

This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.

Report a problem with this summary